{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:14:12Z","timestamp":1789964052618,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:00:00Z","timestamp":1414627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s12265-014-9594-0","type":"journal-article","created":{"date-parts":[[2014,10,29]],"date-time":"2014-10-29T14:40:44Z","timestamp":1414593644000},"page":"769-780","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Rationale and Design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (The POSEIDON-DCM Study)"],"prefix":"10.1007","volume":"7","author":[{"given":"Muzammil","family":"Mushtaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darcy L.","family":"DiFede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Golpanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisha","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samirah A.","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan W.","family":"Heldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M.","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,10,30]]},"reference":[{"key":"9594_CR1","volume-title":"Braunwald\u2019s Heart Disease: a textbook of cardiovascular medicine","author":"JM Hare","year":"2011","unstructured":"Hare, J. M. (2011). The dilated, restrictive and infiltrative cardiomyopathies. In R. O. M. D. L. Bonow, D. P. Zipes, & P. Libby (Eds.), Braunwald\u2019s Heart Disease: a textbook of cardiovascular medicine. Philadelphia: Saunders Elsevier."},{"key":"9594_CR2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/0735-1097(92)90243-G","volume":"20","author":"JM Hare","year":"1992","unstructured":"Hare, J. M., Walford, G. D., Hruban, R. H., Hutchins, G. M., Deckers, J. W., & Baughman, K. L. (1992). Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease. Journal of the American College of Cardiology, 20, 1318\u20131325.","journal-title":"Journal of the American College of Cardiology"},{"key":"9594_CR3","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/j.jacc.2009.06.055","volume":"54","author":"JM Hare","year":"2009","unstructured":"Hare, J. M., Traverse, J. H., Henry, T. D., Dib, N., Strumpf, R. K., Schulman, S. P., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54, 2277\u20132286.","journal-title":"Journal of the American College of Cardiology"},{"key":"9594_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman, A. W., DiFede, D. L., Fishman, J. E., Zambrano, J. P., Trachtenberg, B. H., Karantalis, V., et al. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA, 311, 62\u201373.","journal-title":"JAMA"},{"key":"9594_CR5","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.jacc.2009.02.051","volume":"53","author":"M Yousef","year":"2009","unstructured":"Yousef, M., Schannwell, C. M., Kostering, M., Zeus, T., Brehm, M., & Strauer, B. E. (2009). The balance study: clinical benefit and long-term outcome after intracoronary autologous bone marrow cell transplantation in patients with acute myocardial infarction. Journal of the American College of Cardiology, 53, 2262\u20132269.","journal-title":"Journal of the American College of Cardiology"},{"key":"9594_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","volume":"112","author":"B Vrtovec","year":"2013","unstructured":"Vrtovec, B., Poglajen, G., Lezaic, L., Sever, M., Domanovic, D., Cernelc, P., et al. (2013). Effects of intracoronary cd34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up. Circulation Research, 112, 165\u2013173.","journal-title":"Circulation Research"},{"key":"9594_CR7","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., et al. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The poseidon randomized trial. JAMA, 308, 2369\u20132379.","journal-title":"JAMA"},{"key":"9594_CR8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-62703-505-7_8","volume":"1037","author":"JS Silva Da","year":"2013","unstructured":"Da Silva, J. S., & Hare, J. M. (2013). Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. Methods in Molecular Biology, 1037, 145\u2013163.","journal-title":"Methods in Molecular Biology"},{"key":"9594_CR9","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","volume":"60","author":"K Thygesen","year":"2012","unstructured":"Thygesen, K., Alpert, J. S., Jaffe, A. S., Simoons, M. L., Chaitman, B. R., White, H. D., et al. (2012). Third universal definition of myocardial infarction. Journal of the American College of Cardiology, 60, 1581\u20131598.","journal-title":"Journal of the American College of Cardiology"},{"key":"9594_CR10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1161\/CIRCEP.113.000159","volume":"6","author":"T Sasaki","year":"2013","unstructured":"Sasaki, T., Miller, C. F., Hansford, R., Zipunnikov, V., Zviman, M. M., Marine, J. E., et al. (2013). Impact of nonischemic scar features on local ventricular electrograms and scar-related ventricular tachycardia circuits in patients with nonischemic cardiomyopathy. Circulatory Arrhythmia Electrophysiol, 6, 1139\u20131147.","journal-title":"Circulatory Arrhythmia Electrophysiol"},{"key":"9594_CR11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/CIRCRESAHA.111.241380","volume":"108","author":"D D\u2019Amario","year":"2011","unstructured":"D\u2019Amario, D., Fiorini, C., Campbell, P. M., Goichberg, P., Sanada, F., Zheng, H., et al. (2011). Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circulation Research, 108, 857\u2013861.","journal-title":"Circulation Research"},{"key":"9594_CR12","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","volume":"378","author":"R Bolli","year":"2011","unstructured":"Bolli, R., Chugh, A. R., D\u2019Amario, D., Loughran, J. H., Stoddard, M. F., Ikram, S., et al. (2011). Cardiac stem cells in patients with ischaemic cardiomyopathy (scipio): initial results of a randomised phase 1 trial. Lancet, 378, 1847\u20131857.","journal-title":"Lancet"},{"key":"9594_CR13","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1093\/eurheartj\/ehp549","volume":"31","author":"B Heidecker","year":"2010","unstructured":"Heidecker, B., Lamirault, G., Kasper, E. K., Wittstein, I. S., Champion, H. C., Breton, E., et al. (2010). The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences. European Heart Journal, 31, 1188\u20131196.","journal-title":"European Heart Journal"},{"key":"9594_CR14","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1073\/pnas.0504388102","volume":"102","author":"LC Amado","year":"2005","unstructured":"Amado, L. C., Saliaris, A. P., Schuleri, K. H., St John, M., Xie, J. S., Cattaneo, S., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 102, 11474\u201311479.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9594_CR15","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.jacc.2006.06.073","volume":"48","author":"LC Amado","year":"2006","unstructured":"Amado, L. C., Schuleri, K. H., Saliaris, A. P., Boyle, A. J., Helm, R., Oskouei, B., et al. (2006). Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. Journal of the American College of Cardiology, 48, 2116\u20132124.","journal-title":"Journal of the American College of Cardiology"},{"key":"9594_CR16","first-page":"666","volume":"14","author":"K Parakh","year":"2012","unstructured":"Parakh, K., Kittleson, M. M., Heidecker, B., Wittstein, I. S., Judge, D. P., Champion, H. C., et al. (2012). The variable natural history of idiopathic dilated cardiomyopathy. Israel Medical Association Journal : IMAJ, 14, 666\u2013671.","journal-title":"Israel Medical Association Journal : IMAJ"},{"key":"9594_CR17","first-page":"29","volume-title":"Atlas of Heart Failure","author":"JM Hare","year":"2008","unstructured":"Hare, J. M. (2008). The etiologic basis of congestive heart failure. In W. S. Colucci (Ed.), Atlas of Heart Failure (pp. 29\u201356). Philadelphia: Springer."},{"key":"9594_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","volume":"355","author":"TE Owan","year":"2006","unstructured":"Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006). Trends in prevalence and outcome of heart failure with preserved ejection fraction. New England Journal of Medicine, 355, 251\u2013259.","journal-title":"New England Journal of Medicine"},{"key":"9594_CR19","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.105.584102","volume":"113","author":"WC Levy","year":"2006","unstructured":"Levy, W. C., Mozaffarian, D., Linker, D. T., Sutradhar, S. C., Anker, S. D., Cropp, A. B., et al. (2006). The Seattle heart failure model: prediction of survival in heart failure. Circulation, 113, 1424\u20131433.","journal-title":"Circulation"},{"key":"9594_CR20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/CIRCULATIONAHA.107.756544","volume":"118","author":"B Heidecker","year":"2008","unstructured":"Heidecker, B., Kasper, E. K., Wittstein, I. S., Champion, H. C., Breton, E., Russell, S. D., et al. (2008). Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. Circulation, 118, 238\u2013246.","journal-title":"Circulation"},{"key":"9594_CR21","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCULATIONAHA.110.002857","volume":"123","author":"B Heidecker","year":"2011","unstructured":"Heidecker, B., Kittleson, M. M., Kasper, E. K., Wittstein, I. S., Champion, H. C., Russell, S. D., et al. (2011). Transcriptomic biomarkers for the accurate diagnosis of myocarditis. Circulation, 123, 1174\u20131184.","journal-title":"Circulation"},{"key":"9594_CR22","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1590\/S0100-879X2010007500093","volume":"43","author":"HF Martino","year":"2010","unstructured":"Martino, H. F., Oliveira, P. S., Souza, F. C., Costa, P. C., Assuncao, E. S. E., Villela, R., et al. (2010). A safety and feasibility study of cell therapy in dilated cardiomyopathy. Brazilian Journal of Medical and Biological Research, 43, 989\u2013995.","journal-title":"Brazilian Journal of Medical and Biological Research"},{"key":"9594_CR23","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","volume":"27","author":"T Freyman","year":"2006","unstructured":"Freyman, T., Polin, G., Osman, H., Crary, J., Lu, M., Cheng, L., et al. (2006). A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. European Heart Journal, 27, 1114\u20131122.","journal-title":"European Heart Journal"},{"key":"9594_CR24","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.yjmcc.2007.09.012","volume":"44","author":"EC Perin","year":"2008","unstructured":"Perin, E. C., Silva, G. V., Assad, J. A., Vela, D., Buja, L. M., Sousa, A. L., et al. (2008). Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. Journal of Molecular and Cellular Cardiology, 44, 486\u2013495.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"9594_CR25","first-page":"142","volume":"3","author":"EC Perin","year":"2007","unstructured":"Perin, E. C., Silva, G. V., Fernandes, M. R., Munger, T., Pandey, A., Sehra, R., et al. (2007). First experience with remote left ventricular mapping and transendocardial cell injection with a novel integrated magnetic navigation-guided electromechanical mapping system. EuroIntervention : Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 3, 142\u2013148.","journal-title":"EuroIntervention : Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology"},{"key":"9594_CR26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ahj.2012.05.026","volume":"164","author":"AB Mathiasen","year":"2012","unstructured":"Mathiasen, A. B., Jorgensen, E., Qayyum, A. A., Haack-Sorensen, M., Ekblond, A., & Kastrup, J. (2012). Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived mesenchymal stromal cells in chronic ischemic heart failure (MSC-HF trial). American Heart Journal, 164, 285\u2013291.","journal-title":"American Heart Journal"},{"key":"9594_CR27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1752-8062.2012.00432.x","volume":"5","author":"JM Duran","year":"2012","unstructured":"Duran, J. M., Taghavi, S., Berretta, R. M., Makarewich, C. A., Sharp Iii, T., Starosta, T., et al. (2012). A characterization and targeting of the infarct border zone in a swine model of myocardial infarction. Clinical and Translational Science, 5, 416\u2013421.","journal-title":"Clinical and Translational Science"},{"key":"9594_CR28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijcard.2012.11.063","volume":"165","author":"AN Kharlamov","year":"2013","unstructured":"Kharlamov, A. N., Duckers, H. J., van Beusekom, H. M., Smits, P. C., Perin, E. C., & Serruys, P. W. (2013). Do we have a future with transcatheter adventitial delivery of stem cells? International Journal of Cardiology, 165, 217\u2013221.","journal-title":"International Journal of Cardiology"},{"key":"9594_CR29","first-page":"9","volume":"2","author":"N Dib","year":"2009","unstructured":"Dib, N., Dinsmore, J., Lababidi, Z., White, B., Moravec, S., Campbell, A., et al. (2009). One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). Journal of the American College of Cardiology: Cardiovascular Interventions, 2, 9\u201316.","journal-title":"Journal of the American College of Cardiology: Cardiovascular Interventions"},{"key":"9594_CR30","first-page":"417","volume":"1","author":"PC Smits","year":"2006","unstructured":"Smits, P. C., Nienaber, C., Colombo, A., Ince, H., Carlino, M., Theuns, D. A., et al. (2006). Myocardial repair by percutaneous cell transplantation of autologous skeletal myoblast as a standalone procedure in post myocardial infarction chronic heart failure patients. EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 1, 417\u2013424.","journal-title":"EuroIntervention: Journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology"},{"key":"9594_CR31","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.jacc.2003.06.017","volume":"42","author":"PC Smits","year":"2003","unstructured":"Smits, P. C., van Geuns, R. J., Poldermans, D., Bountioukos, M., Onderwater, E. E., Lee, C. H., et al. (2003). Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up. Journal of the American College of Cardiology, 42, 2063\u20132069.","journal-title":"Journal of the American College of Cardiology"},{"key":"9594_CR32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCRESAHA.111.243147","volume":"109","author":"AR Williams","year":"2011","unstructured":"Williams, A. R., & Hare, J. M. (2011). Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circulation Research, 109, 923\u2013940.","journal-title":"Circulation Research"},{"key":"9594_CR33","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1073\/pnas.0903201106","volume":"106","author":"HC Quevedo","year":"2009","unstructured":"Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., Feigenbaum, G. S., Rodriguez, J. E., Valdes, D., et al. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America, 106, 14022\u201314027.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9594_CR34","unstructured":"Singla DK, Abdelli LS.\u00a0(2014). Embryonic stem cells and released factors stimulate c-kit\/flk-1 progenitor cells and promote neovascularization in doxorubicin-induced cardiomyopathy. Cell Transplant."},{"key":"9594_CR35","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00395-012-0252-x","volume":"107","author":"S Rupp","year":"2012","unstructured":"Rupp, S., Bauer, J., von Gerlach, S., Fichtlscherer, S., Zeiher, A. M., Dimmeler, S., et al. (2012). Pressure overload leads to an increase of cardiac resident stem cells. Basic Research in Cardiology, 107, 252.","journal-title":"Basic Research in Cardiology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-014-9594-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12265-014-9594-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-014-9594-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T02:56:30Z","timestamp":1559444190000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12265-014-9594-0"}},"subtitle":["A phase I\/II, Randomized Pilot Study of the Comparative Safety and Efficacy of Transendocardial Injection of Autologous Mesenchymal Stem Cell vs. Allogeneic Mesenchymal Stem Cells in Patients with Non-ischemic Dilated Cardiomyopathy"],"short-title":[],"issued":{"date-parts":[[2014,10,30]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9594"],"URL":"https:\/\/doi.org\/10.1007\/s12265-014-9594-0","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,30]]}}}